FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001285874> ?p ?o ?g. }

• W2001285874 endingPage "2161" @default.
• W2001285874 startingPage "2155" @default.
• W2001285874 abstract "Background Thrombolytic therapy improves survival after myocardial infarction through reperfusion of the infarct-related artery. Thrombin generated during thrombolytic administration may reduce the efficacy of thrombolysis. A direct thrombin inhibitor may improve early patency rates. Methods and Results Four hundred twelve patients presenting within 12 hours with ST-segment elevation were given aspirin and streptokinase and randomized in a double-blind manner to receive up to 60 hours of either heparin (5000 U bolus followed by 1000 to 1200 U/h), low-dose hirulog (0.125 mg/kg bolus followed by 0.25 mg · kg −1 · h −1 for 12 hours then 0.125 mg · kg −1 · h −1 ), or high-dose hirulog (0.25 mg/kg bolus followed by 0.5 mg · kg −1 · h −1 for 12 hours then 0.25 mg · kg −1 · h −1 ). The primary outcome was Thrombolysis In Myocardial Infarction trial (TIMI) grade 3 flow of the infarct-related artery at 90 to 120 minutes. TIMI 3 flow was 35% (95% CI, 28% to 44%) with heparin, 46% (95% CI, 38% to 55%) with low-dose hirulog, and 48% (95% CI, 40% to 57%) with high-dose hirulog (heparin versus hirulog, P =.023; heparin versus high-dose hirulog, P =.03). At 48 hours, reocclusion had occurred in 7% of heparin, 5% of low-dose hirulog, and 1% of high-dose hirulog patients ( P =NS). By 35 days, death, cardiogenic shock, or reinfarction had occurred in 25 heparin (17.9%), 19 low-dose hirulog (14%), and 17 high-dose hirulog patients (12.5%) ( P =NS). Two strokes occurred with heparin, none with low-dose hirulog, and two with high-dose hirulog. Major bleeding (40% from the groin site) occurred in 28% of heparin, 14% of low-dose hirulog, and 19% of high-dose hirulog patients (heparin versus low-dose hirulog, P <.01). Conclusions Hirulog was more effective than heparin in producing early patency in patients treated with aspirin and streptokinase without increasing the risk of major bleeding. Direct thrombin inhibition may improve clinical outcome." @default.
• W2001285874 created "2016-06-24" @default.
• W2001285874 creator A5015113254 @default.
• W2001285874 creator A5017226541 @default.
• W2001285874 creator A5025860174 @default.
• W2001285874 creator A5032969600 @default.
• W2001285874 creator A5033070568 @default.
• W2001285874 creator A5048447246 @default.
• W2001285874 creator A5049334788 @default.
• W2001285874 creator A5053576758 @default.
• W2001285874 creator A5062843291 @default.
• W2001285874 creator A5083852489 @default.
• W2001285874 creator A5089106689 @default.
• W2001285874 creator A5090621185 @default.
• W2001285874 date "1997-10-07" @default.
• W2001285874 modified "2023-10-16" @default.
• W2001285874 title "Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)" @default.
• W2001285874 cites W1533600198 @default.
• W2001285874 cites W1596397105 @default.
• W2001285874 cites W2001796803 @default.
• W2001285874 cites W2008305192 @default.
• W2001285874 cites W2050928004 @default.
• W2001285874 cites W2138849164 @default.
• W2001285874 cites W2162356386 @default.
• W2001285874 cites W2170309901 @default.
• W2001285874 cites W2322445769 @default.
• W2001285874 cites W2335915210 @default.
• W2001285874 cites W2438398765 @default.
• W2001285874 cites W25610714 @default.
• W2001285874 cites W4231431115 @default.
• W2001285874 cites W4251417417 @default.
• W2001285874 doi "https://doi.org/10.1161/01.cir.96.7.2155" @default.
• W2001285874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9337184" @default.
• W2001285874 hasPublicationYear "1997" @default.
• W2001285874 type Work @default.
• W2001285874 sameAs 2001285874 @default.
• W2001285874 citedByCount "213" @default.
• W2001285874 countsByYear W20012858742012 @default.
• W2001285874 countsByYear W20012858742013 @default.
• W2001285874 countsByYear W20012858742015 @default.
• W2001285874 countsByYear W20012858742016 @default.
• W2001285874 countsByYear W20012858742017 @default.
• W2001285874 countsByYear W20012858742018 @default.
• W2001285874 countsByYear W20012858742019 @default.
• W2001285874 countsByYear W20012858742021 @default.
• W2001285874 crossrefType "journal-article" @default.
• W2001285874 hasAuthorship W2001285874A5015113254 @default.
• W2001285874 hasAuthorship W2001285874A5017226541 @default.
• W2001285874 hasAuthorship W2001285874A5025860174 @default.
• W2001285874 hasAuthorship W2001285874A5032969600 @default.
• W2001285874 hasAuthorship W2001285874A5033070568 @default.
• W2001285874 hasAuthorship W2001285874A5048447246 @default.
• W2001285874 hasAuthorship W2001285874A5049334788 @default.
• W2001285874 hasAuthorship W2001285874A5053576758 @default.
• W2001285874 hasAuthorship W2001285874A5062843291 @default.
• W2001285874 hasAuthorship W2001285874A5083852489 @default.
• W2001285874 hasAuthorship W2001285874A5089106689 @default.
• W2001285874 hasAuthorship W2001285874A5090621185 @default.
• W2001285874 hasConcept C126322002 @default.
• W2001285874 hasConcept C141071460 @default.
• W2001285874 hasConcept C2776336681 @default.
• W2001285874 hasConcept C2776850375 @default.
• W2001285874 hasConcept C2777557582 @default.
• W2001285874 hasConcept C2777628954 @default.
• W2001285874 hasConcept C2777995511 @default.
• W2001285874 hasConcept C2779581417 @default.
• W2001285874 hasConcept C42219234 @default.
• W2001285874 hasConcept C43376680 @default.
• W2001285874 hasConcept C500558357 @default.
• W2001285874 hasConcept C71924100 @default.
• W2001285874 hasConceptScore W2001285874C126322002 @default.
• W2001285874 hasConceptScore W2001285874C141071460 @default.
• W2001285874 hasConceptScore W2001285874C2776336681 @default.
• W2001285874 hasConceptScore W2001285874C2776850375 @default.
• W2001285874 hasConceptScore W2001285874C2777557582 @default.
• W2001285874 hasConceptScore W2001285874C2777628954 @default.
• W2001285874 hasConceptScore W2001285874C2777995511 @default.
• W2001285874 hasConceptScore W2001285874C2779581417 @default.
• W2001285874 hasConceptScore W2001285874C42219234 @default.
• W2001285874 hasConceptScore W2001285874C43376680 @default.
• W2001285874 hasConceptScore W2001285874C500558357 @default.
• W2001285874 hasConceptScore W2001285874C71924100 @default.
• W2001285874 hasIssue "7" @default.
• W2001285874 hasLocation W20012858741 @default.
• W2001285874 hasLocation W20012858742 @default.
• W2001285874 hasOpenAccess W2001285874 @default.
• W2001285874 hasPrimaryLocation W20012858741 @default.
• W2001285874 hasRelatedWork W1503143151 @default.
• W2001285874 hasRelatedWork W1968435240 @default.
• W2001285874 hasRelatedWork W1975495438 @default.
• W2001285874 hasRelatedWork W2049757768 @default.
• W2001285874 hasRelatedWork W2056873483 @default.
• W2001285874 hasRelatedWork W2063377325 @default.
• W2001285874 hasRelatedWork W2089042173 @default.
• W2001285874 hasRelatedWork W2102093589 @default.
• W2001285874 hasRelatedWork W2155607579 @default.
• W2001285874 hasRelatedWork W2394945591 @default.
• W2001285874 hasVolume "96" @default.

• next